3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
53
Breast Neoplasms
13
Polycystic Ovary Syndrome
8
Infertility
6
Ovarian Hyperstimulation Syndrome
3
Neoplasms
3
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Prostate Adenocarcinoma
2
Osteosarcoma
2
Uterine Anomalies
1
The Neoadjuvant Therapy
1
Sleep Wake Disorders
1
Salpingitis
1
Salivary Gland Neoplasms
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Neoplasm Metastasis
1
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
1
Myofibroma
1
Metabolic Syndrome
1
Leiomyoma
1
Infertility, Female
1
Hypogonadism
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Helping Behavior
1
Fatty Liver
1
Fatigue
1
Interventions
Yoga
2
Methylphenidate
2
Melatonin
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
Cognitive Behavioral Therapy
2
Behavior Therapy
2
exemestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Valeriana extract
1
Uncertainty
1
Ultraviolet Therapy
1
Triptorelin Pamoate
1
Therapeutics
1
Tamoxifen
1
Surveys and Questionnaires
1
Saline Solution
1
Psychosocial Intervention
1
Phototherapy
1
N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide
1
Modafinil
1
Methods
1
Methadone
1
Hypnosis
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Donepezil
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sleep Wake Disorders
×
Triptorelin Pamoate
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts